{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:48:48Z","timestamp":1791308928370,"version":"4.3.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s12035-023-03594-3","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T10:02:46Z","timestamp":1693303366000},"page":"533-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Calpain as a Therapeutic Target for Hypoxic-Ischemic Encephalopathy"],"prefix":"10.1007","volume":"61","author":[{"given":"Ruiyang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2442-2334","authenticated-orcid":false,"given":"Yanchao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"issue":"2","key":"3594_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.clp.2018.01.015","volume":"45","author":"CM Novak","year":"2018","unstructured":"Novak CM, Ozen M, Burd I (2018) Perinatal brain injury: mechanisms, prevention, and outcomes. Clin Perinatol 45(2):357\u2013375. https:\/\/doi.org\/10.1016\/j.clp.2018.01.015","journal-title":"Clin Perinatol"},{"issue":"2","key":"3594_CR2","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.siny.2020.101084","volume":"25","author":"A Sanchez-Illana","year":"2020","unstructured":"Sanchez-Illana A, Pineiro-Ramos JD, Kuligowski J (2020) Small molecule biomarkers for neonatal hypoxic ischemic encephalopathy. Semin Fetal Neonatal Med 25(2):101084. https:\/\/doi.org\/10.1016\/j.siny.2020.101084","journal-title":"Semin Fetal Neonatal Med"},{"issue":"6","key":"3594_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","volume":"86","author":"JJ Kurinczuk","year":"2010","unstructured":"Kurinczuk JJ, White-Koning M, Badawi N (2010) Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 86(6):329\u2013338. https:\/\/doi.org\/10.1016\/j.earlhumdev.2010.05.010","journal-title":"Early Hum Dev"},{"key":"3594_CR4","doi-asserted-by":"publisher","first-page":"609813","DOI":"10.1155\/2011\/609813","volume":"2011","author":"MC Lai","year":"2011","unstructured":"Lai MC, Yang SN (2011) Perinatal hypoxic-ischemic encephalopathy. J Biomed Biotechnol 2011:609813. https:\/\/doi.org\/10.1155\/2011\/609813","journal-title":"J Biomed Biotechnol"},{"issue":"2 Suppl","key":"3594_CR5","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.jpeds.2010.11.014","volume":"158","author":"M Perlman","year":"2011","unstructured":"Perlman M, Shah PS (2011) Hypoxic-ischemic encephalopathy: challenges in outcome and prediction. J Pediatr 158(2 Suppl):e51-54. https:\/\/doi.org\/10.1016\/j.jpeds.2010.11.014","journal-title":"J Pediatr"},{"key":"3594_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fneur.2012.00185","volume":"3","author":"M Douglas-Escobar","year":"2012","unstructured":"Douglas-Escobar M, Weiss MD (2012) Biomarkers of brain injury in the premature infant. Front Neurol 3:185. https:\/\/doi.org\/10.3389\/fneur.2012.00185","journal-title":"Front Neurol"},{"issue":"22","key":"3594_CR7","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.3969\/j.issn.1006-2084.2020.22.017","volume":"26","author":"WQ Huang","year":"2020","unstructured":"Huang WQ, Zhang W, Liu WW (2020) Research progress in drug therapy for neonatal hypoxic ischemic encephalopathy. Med Recapotulate 26(22):4457\u20134461. https:\/\/doi.org\/10.3969\/j.issn.1006-2084.2020.22.017","journal-title":"Med Recapotulate"},{"key":"3594_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jconrel.2020.12.056","volume":"330","author":"R Narayanamurthy","year":"2021","unstructured":"Narayanamurthy R, Yang JJ, Yager JY, Unsworth LD (2021) Drug delivery platforms for neonatal brain injury. J Control Release 330:765\u2013787. https:\/\/doi.org\/10.1016\/j.jconrel.2020.12.056","journal-title":"J Control Release"},{"issue":"9","key":"3594_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.7499\/j.issn.1008-8830.2016.09.024","volume":"18","author":"R Zou","year":"2016","unstructured":"Zou R, Mu DZ (2016) prevention and treatment of energy failure in neonates with hypoxic-ischemic encephalopathy. Zhongguo Dang Dai Er Ke Za Zhi 18(9):915\u2013920. https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2016.09.024","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"1","key":"3594_CR10","first-page":"9","volume":"1","author":"D Adstamongkonkul","year":"2017","unstructured":"Adstamongkonkul D, Hess DC (2017) Ischemic conditioning and neonatal hypoxic ischemic encephalopathy: a literature review. Cond Med 1(1):9\u201316","journal-title":"Cond Med"},{"key":"3594_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fped.2014.00144","volume":"2","author":"US Bhalala","year":"2014","unstructured":"Bhalala US, Koehler RC, Kannan S (2014) Neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brain. Front Pediatr 2:144. https:\/\/doi.org\/10.3389\/fped.2014.00144","journal-title":"Front Pediatr"},{"issue":"4","key":"3594_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamapediatrics.2014.3269","volume":"169","author":"M Douglas-Escobar","year":"2015","unstructured":"Douglas-Escobar M, Weiss MD (2015) Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr 169(4):397\u2013403. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.3269","journal-title":"JAMA Pediatr"},{"issue":"4","key":"3594_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3760\/cma.j.issn.0254-1416.2016.04.027","volume":"36","author":"JC Zhu","year":"2016","unstructured":"Zhu JC, Peng ZH, Teng XF et al (2016) Efficacy of het0016 for improving delayed mild hypothermia-induced protection of rat neurons subjected to oxygen-glucose deprivation and restoration in vitro. Chin J Anesthesiol 36(4):484\u2013487. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-1416.2016.04.027","journal-title":"Chin J Anesthesiol"},{"key":"3594_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3760\/cma.j.issn.0254-1416.2016.04.033","volume":"36","author":"JC Zhu","year":"2016","unstructured":"Zhu JC, Bai WY, Yang YC et al (2016) Effect of het0016 combined with mild hypothermia on expression of m-calpain protein in cerebral neurons of neonatal piglets with hypoxic-ischemic encephalopathy. Chin J Anesthesiol 36:505\u2013507. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-1416.2016.04.033","journal-title":"Chin J Anesthesiol"},{"issue":"7","key":"3594_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/s1357-2725(02)00009-2","volume":"34","author":"BJ Perrin","year":"2002","unstructured":"Perrin BJ, Huttenlocher A (2002) Calpain. Int J Biochem Cell Biol 34(7):722\u2013725. https:\/\/doi.org\/10.1016\/s1357-2725(02)00009-2","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"3594_CR16","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s11064-021-03521-9","volume":"47","author":"H Khan","year":"2022","unstructured":"Khan H, Garg N, Singh TG, Kaur A, Thapa K (2022) Calpain inhibitors as potential therapeutic modulators in neurodegenerative diseases. Neurochem Res 47(5):1125\u20131149. https:\/\/doi.org\/10.1007\/s11064-021-03521-9","journal-title":"Neurochem Res"},{"issue":"3","key":"3594_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1385\/MN:33:3:215","volume":"33","author":"HY Wu","year":"2006","unstructured":"Wu HY, Lynch DR (2006) Calpain and synaptic function. Mol Neurobiol 33(3):215\u2013236. https:\/\/doi.org\/10.1385\/MN:33:3:215","journal-title":"Mol Neurobiol"},{"issue":"4","key":"3594_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.tins.2016.01.007","volume":"39","author":"M Baudry","year":"2016","unstructured":"Baudry M, Bi X (2016) Calpain-1 and calpain-2: the yin and yang of synaptic plasticity and neurodegeneration. Trends Neurosci 39(4):235\u2013245. https:\/\/doi.org\/10.1016\/j.tins.2016.01.007","journal-title":"Trends Neurosci"},{"issue":"11","key":"3594_CR19","doi-asserted-by":"publisher","first-page":"BSR20200552","DOI":"10.1042\/BSR20200552","volume":"40","author":"F Shinkai-Ouchi","year":"2020","unstructured":"Shinkai-Ouchi F, Shindo M, Doi N, Hata S, Ono Y (2020) Calpain-2 participates in the process of calpain-1 inactivation. Biosci Rep 40(11):BSR20200552. https:\/\/doi.org\/10.1042\/BSR20200552","journal-title":"Biosci Rep"},{"issue":"3","key":"3594_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1152\/physrev.00029.2002","volume":"83","author":"DE Goll","year":"2003","unstructured":"Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83(3):731\u2013801. https:\/\/doi.org\/10.1152\/physrev.00029.2002","journal-title":"Physiol Rev"},{"issue":"4","key":"3594_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/17460441.2020.1722638","volume":"15","author":"LE Dokus","year":"2020","unstructured":"Dokus LE, Yousef M, Banoczi Z (2020) Modulators of calpain activity: inhibitors and activators as potential drugs. Expert Opin Drug Discov 15(4):471\u2013486. https:\/\/doi.org\/10.1080\/17460441.2020.1722638","journal-title":"Expert Opin Drug Discov"},{"issue":"1\u20132","key":"3594_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11064-015-1752-5","volume":"41","author":"IL Salazar","year":"2016","unstructured":"Salazar IL, Caldeira MV, Curcio M, Duarte CB (2016) The role of proteases in hippocampal synaptic plasticity: putting together small pieces of a complex puzzle. Neurochem Res 41(1\u20132):156\u2013182. https:\/\/doi.org\/10.1007\/s11064-015-1752-5","journal-title":"Neurochem Res"},{"issue":"9","key":"3594_CR23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1515\/hsz-2012-0143","volume":"393","author":"H Sorimachi","year":"2012","unstructured":"Sorimachi H, Mamitsuka H, Ono Y (2012) Understanding the substrate specificity of conventional calpains. Biol Chem 393(9):853\u2013871. https:\/\/doi.org\/10.1515\/hsz-2012-0143","journal-title":"Biol Chem"},{"issue":"23","key":"3594_CR24","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMra043361","volume":"352","author":"M Zatz","year":"2005","unstructured":"Zatz M, Starling A (2005) Calpains and disease. N Engl J Med 352(23):2413\u20132423. https:\/\/doi.org\/10.1056\/NEJMra043361","journal-title":"N Engl J Med"},{"issue":"28","key":"3594_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3969\/j.issn.1674-4985.2015.28.005","volume":"12","author":"CS Kuang","year":"2015","unstructured":"Kuang CS, Xu H, Huang Z et al (2015) The protective effect of calpain inhibitor against focal cerebral ischemia-reperfusion injury in rats. Med Innov China 12(28):15\u201318. https:\/\/doi.org\/10.3969\/j.issn.1674-4985.2015.28.005","journal-title":"Med Innov China"},{"issue":"3","key":"3594_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1042\/AN20130002","volume":"5","author":"H Li","year":"2013","unstructured":"Li H, Zhang N, Sun G, Ding S (2013) Inhibition of the group I mGluRs reduces acute brain damage and improves long-term histological outcomes after photothrombosis-induced ischaemia. ASN Neuro 5(3):195\u2013207. https:\/\/doi.org\/10.1042\/AN20130002","journal-title":"ASN Neuro"},{"issue":"1","key":"3594_CR27","first-page":"13","volume":"26","author":"B Zheng","year":"2011","unstructured":"Zheng B, Wu X, Yang L (2011) Dynamic changes of calpain1 and calpain2 after traumatic brain injury in rats. China Med Univ 26(1):13\u201315","journal-title":"China Med Univ"},{"issue":"2","key":"3594_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neulet.2010.05.040","volume":"479","author":"X Cao","year":"2010","unstructured":"Cao X, Zhang Y, Zou L, Xiao H, Chu Y, Chu X (2010) Persistent oxygen-glucose deprivation induces astrocytic death through two different pathways and calpain-mediated proteolysis of cytoskeletal proteins during astrocytic oncosis. Neurosci Lett 479(2):118\u2013122. https:\/\/doi.org\/10.1016\/j.neulet.2010.05.040","journal-title":"Neurosci Lett"},{"issue":"5","key":"3594_CR29","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s004010000290","volume":"101","author":"M Brodhun","year":"2001","unstructured":"Brodhun M, Fritz H, Walter B, Antonow-Schlorke I, Reinhart K, Zwiener U, Bauer R, Patt S (2001) Immunomorphological sequelae of severe brain injury induced by fluid-percussion in juvenile pigs\u2013effects of mild hypothermia. Acta Neuropathol 101(5):424\u2013434. https:\/\/doi.org\/10.1007\/s004010000290","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3594_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neuron.2019.06.002","volume":"103","author":"DK Sandsmark","year":"2019","unstructured":"Sandsmark DK, Bashir A, Wellington CL, Diaz-Arrastia R (2019) Cerebral microvascular injury: a potentially treatable endophenotype of traumatic brain injury-induced neurodegeneration. Neuron 103(3):367\u2013379. https:\/\/doi.org\/10.1016\/j.neuron.2019.06.002","journal-title":"Neuron"},{"issue":"6","key":"3594_CR31","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1007\/s12035-020-01904-7","volume":"57","author":"M Gamdzyk","year":"2020","unstructured":"Gamdzyk M, Doycheva DM, Araujo C, Ocak U, Luo Y, Tang J, Zhang JH (2020) cGAS\/STING pathway activation contributes to delayed neurodegeneration in neonatal hypoxia-ischemia rat model: possible involvement of LINE-1. Mol Neurobiol 57(6):2600\u20132619. https:\/\/doi.org\/10.1007\/s12035-020-01904-7","journal-title":"Mol Neurobiol"},{"key":"3594_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jcrc.2019.12.021","volume":"56","author":"MA Hausburg","year":"2020","unstructured":"Hausburg MA, Banton KL, Roman PE, Salgado F, Baek P, Waxman MJ, Tanner A 2nd, Yoder J et al (2020) Effects of propofol on ischemia-reperfusion and traumatic brain injury. J Crit Care 56:281\u2013287. https:\/\/doi.org\/10.1016\/j.jcrc.2019.12.021","journal-title":"J Crit Care"},{"issue":"3","key":"3594_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10565-021-09634-9","volume":"38","author":"H Shi","year":"2022","unstructured":"Shi H, Yu Y, Liu X, Yu Y, Li M, Wang Y, Zou Y, Chen R (2022) Inhibition of calpain reduces cell apoptosis by suppressing mitochondrial fission in acute viral myocarditis. Cell Biol Toxicol 38(3):487\u2013504. https:\/\/doi.org\/10.1007\/s10565-021-09634-9","journal-title":"Cell Biol Toxicol"},{"issue":"15","key":"3594_CR34","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1111\/j.1742-4658.2006.05352.x","volume":"273","author":"F Raynaud","year":"2006","unstructured":"Raynaud F, Marcilhac A (2006) Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer\u2019s disease. FEBS J 273(15):3437\u20133443. https:\/\/doi.org\/10.1111\/j.1742-4658.2006.05352.x","journal-title":"FEBS J"},{"issue":"1\u20132","key":"3594_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.brainres.2005.01.080","volume":"1040","author":"A Kambe","year":"2005","unstructured":"Kambe A, Yokota M, Saido TC, Satokata I, Fujikawa H, Tabuchi S, Kamitani H, Watanabe T (2005) Spatial resolution of calpain-catalyzed proteolysis in focal cerebral ischemia. Brain Res 1040(1\u20132):36\u201343. https:\/\/doi.org\/10.1016\/j.brainres.2005.01.080","journal-title":"Brain Res"},{"issue":"1\u20132","key":"3594_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s0006-8993(00)02301-5","volume":"866","author":"A Rami","year":"2000","unstructured":"Rami A, Agarwal R, Botez G, Winckler J (2000) mu-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage. Brain Res 866(1\u20132):299\u2013312. https:\/\/doi.org\/10.1016\/s0006-8993(00)02301-5","journal-title":"Brain Res"},{"issue":"3","key":"3594_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1006\/nbdi.2002.0526","volume":"10","author":"C Zhang","year":"2002","unstructured":"Zhang C, Siman R, Xu YA, Mills AM, Frederick JR, Neumar RW (2002) Comparison of calpain and caspase activities in the adult rat brain after transient forebrain ischemia. Neurobiol Dis 10(3):289\u2013205. https:\/\/doi.org\/10.1006\/nbdi.2002.0526","journal-title":"Neurobiol Dis"},{"key":"3594_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1749-6632.1997.tb48420.x","volume":"825","author":"K Blomgren","year":"1997","unstructured":"Blomgren K, McRae A, Elmered A, Bona E, Kawashima S, Saido TC, Ono T, Hagberg H (1997) The calpain proteolytic system in neonatal hypoxic-ischemia. Ann N Y Acad Sci 825:104\u2013119. https:\/\/doi.org\/10.1111\/j.1749-6632.1997.tb48420.x","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"3594_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.brainres.2004.12.050","volume":"1037","author":"M Kawamura","year":"2005","unstructured":"Kawamura M, Nakajima W, Ishida A, Ohmura A, Miura S, Takada G (2005) Calpain inhibitor MDL 28170 protects hypoxic-ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis. Brain Res 1037(1\u20132):59\u201369. https:\/\/doi.org\/10.1016\/j.brainres.2004.12.050","journal-title":"Brain Res"},{"issue":"3","key":"3594_CR40","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1006\/bbrc.1997.7003","volume":"236","author":"RL Mellgren","year":"1997","unstructured":"Mellgren RL (1997) Evidence for participation of a calpain-like cysteine protease in cell cycle progression through late G1 phase. Biochem Biophys Res Commun 236(3):555\u2013558. https:\/\/doi.org\/10.1006\/bbrc.1997.7003","journal-title":"Biochem Biophys Res Commun"},{"key":"3594_CR41","doi-asserted-by":"publisher","first-page":"102154","DOI":"10.1016\/j.redox.2021.102154","volume":"47","author":"SZ Jia","year":"2021","unstructured":"Jia SZ, Xu XW, Zhang ZH, Chen C, Chen Y-B, Huang S-L, Liu Q, Hoffmann P-R et al (2021) Selenoprotein K deficiency-induced apoptosis: a role for calpain and the ERS pathway. Redox Biol 47:102154. https:\/\/doi.org\/10.1016\/j.redox.2021.102154","journal-title":"Redox Biol"},{"issue":"13","key":"3594_CR42","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3748\/wjg.v26.i13.1450","volume":"26","author":"RJ Xie","year":"2020","unstructured":"Xie RJ, Hu XX, Zheng L, Cai S, Chen Y-S, Yang Y, Yang T, Han B et al (2020) Calpain-2 activity promotes aberrant endoplasmic reticulum stress-related apoptosis in hepatocytes. World J Gastroenterol 26(13):1450\u20131462. https:\/\/doi.org\/10.3748\/wjg.v26.i13.1450","journal-title":"World J Gastroenterol"},{"issue":"9","key":"3594_CR43","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1080\/15548627.2020.1826716","volume":"17","author":"L Peintner","year":"2021","unstructured":"Peintner L, Venkatraman A, Waeldin A, Hofherr A, Busch T, Voronov A, Viau A, Kuehn EW et al (2021) Loss of PKD1\/polycystin-1 impairs lysosomal activity in a CAPN (calpain)-dependent manner. Autophagy 17(9):2384\u20132400. https:\/\/doi.org\/10.1080\/15548627.2020.1826716","journal-title":"Autophagy"},{"issue":"7","key":"3594_CR44","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/hipo.10127","volume":"13","author":"T Yamashima","year":"2003","unstructured":"Yamashima T, Tonchev AB, Tsukada T, Saido TC, Imajoh-Ohmi S, Momoi T, Kominami E (2003) Sustained calpain activation associated with lysosomal rupture executes necrosis of the postischemic CA1 neurons in primates. Hippocampus 13(7):791\u2013800. https:\/\/doi.org\/10.1002\/hipo.10127","journal-title":"Hippocampus"},{"issue":"3\u20134","key":"3594_CR45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ceca.2004.03.001","volume":"36","author":"T Yamashima","year":"2004","unstructured":"Yamashima T (2004) Ca2+-dependent proteases in ischemic neuronal death: a conserved \u201ccalpain-cathepsin cascade\u201d from nematodes to primates. Cell Calcium 36(3\u20134):285\u2013293. https:\/\/doi.org\/10.1016\/j.ceca.2004.03.001","journal-title":"Cell Calcium"},{"issue":"4","key":"3594_CR46","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.pneurobio.2009.09.003","volume":"89","author":"T Yamashima","year":"2009","unstructured":"Yamashima T, Oikawa S (2009) The role of lysosomal rupture in neuronal death. Prog Neurobiol 89(4):343\u2013358. https:\/\/doi.org\/10.1016\/j.pneurobio.2009.09.003","journal-title":"Prog Neurobiol"},{"issue":"6","key":"3594_CR47","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1080\/15548627.2020.1761219","volume":"17","author":"MI Hossain","year":"2021","unstructured":"Hossain MI, Marcus JM, Lee JH, Garcia PL, Singh V, Shacka JJ, Zhang J, Gropen TI et al (2021) Restoration of CTSD (cathepsin D) and lysosomal function in stroke is neuroprotective. Autophagy 17(6):1330\u20131348. https:\/\/doi.org\/10.1080\/15548627.2020.1761219","journal-title":"Autophagy"},{"key":"3594_CR48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.arr.2016.05.008","volume":"32","author":"T Yamashima","year":"2016","unstructured":"Yamashima T (2016) Can \u201ccalpain-cathepsin hypothesis\u201d explain Alzheimer neuronal death? Ageing Res Rev 32:169\u2013179. https:\/\/doi.org\/10.1016\/j.arr.2016.05.008","journal-title":"Ageing Res Rev"},{"issue":"1","key":"3594_CR49","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1021\/acsptsci.0c00217","volume":"4","author":"RC Knopp","year":"2021","unstructured":"Knopp RC, Jastaniah A, Dubrovskyi O, Gaisina I, Tai L, Thatcher GRJ (2021) Extending the calpain-cathepsin hypothesis to the neurovasculature: protection of brain endothelial cells and mice from neurotrauma. ACS Pharmacol Transl Sci 4(1):372\u2013385. https:\/\/doi.org\/10.1021\/acsptsci.0c00217","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"3","key":"3594_CR50","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3390\/ijms23031830","volume":"23","author":"E Martinez-Alonso","year":"2022","unstructured":"Martinez-Alonso E, Guerra-Perez N, Escobar-Peso A, Peracho L, Vera-Lechuga R, Cruz-Culebras A, Masjuan J, Alc\u00e1zar A (2022) Phosphorylation of eukaryotic initiation factor 4G1 (eIF4G1) at Ser1147 is specific for eIF4G1 bound to eIF4E in delayed neuronal death after ischemia. Int J Mol Sci 23(3):1830. https:\/\/doi.org\/10.3390\/ijms23031830","journal-title":"Int J Mol Sci"},{"issue":"S 1-2","key":"3594_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0022-510x(00)00386-5","volume":"179","author":"BC White","year":"2000","unstructured":"White BC, Sullivan JM, DeGracia DJ, O\u2019Neil BJ, Neumar RW, Grossman LI, Rafols JA, Krause GS (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179(S 1-2):1\u201333. https:\/\/doi.org\/10.1016\/s0022-510x(00)00386-5","journal-title":"J Neurol Sci"},{"issue":"7","key":"3594_CR52","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1523\/JNEUROSCI.18-07-02321.1998","volume":"18","author":"RE Westenbroek","year":"1998","unstructured":"Westenbroek RE, Bausch SB, Lin RC, Franck JE, Noebels JL, Catterall WA (1998) Upregulation of L-type Ca2+ channels in reactive astrocytes after brain injury, hypomyelination, and ischemia. J Neurosci 18(7):2321\u20132334. https:\/\/doi.org\/10.1523\/JNEUROSCI.18-07-02321.1998","journal-title":"J Neurosci"},{"issue":"4","key":"3594_CR53","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/sj.jcbfm.9600595","volume":"28","author":"MB Bevers","year":"2008","unstructured":"Bevers MB, Neumar RW (2008) Mechanistic role of calpains in postischemic neurodegeneration. J Cereb Blood Flow Metab 28(4):655\u2013673. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600595","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"3594_CR54","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/(sici)1097-4644(19990915)74:4<522::aid-jcb2>3.3.co;2-9","volume":"74","author":"S Barnoy","year":"1999","unstructured":"Barnoy S, Zipser Y, Glaser T, Grimberg Y, Kosower NS (1999) Association of calpain (Ca(2+)-dependent thiol protease) with its endogenous inhibitor calpastatin in myoblasts. J Cell Biochem 74(4):522\u2013531. https:\/\/doi.org\/10.1002\/(sici)1097-4644(19990915)74:4%3c522::aid-jcb2%3e3.3.co;2-9","journal-title":"J Cell Biochem"},{"issue":"1","key":"3594_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/abbi.2001.2546","volume":"395","author":"T Parr","year":"2001","unstructured":"Parr T, Sensky PL, Bardsley RG, Buttery PJ et al (2001) Calpastatin expression in porcine cardiac and skeletal muscle and partial gene structure. Arch Biochem Biophys 395(1):1\u201313. https:\/\/doi.org\/10.1006\/abbi.2001.2546","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"3594_CR56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.abb.2004.04.001","volume":"427","author":"T Parr","year":"2004","unstructured":"Parr T, Jewell KK, Sensky PL, Brameld JM, Brameld JM, Buttery PJ (2004) Expression of calpastatin isoforms in muscle and functionality of multiple calpastatin promoters. Arch Biochem Biophys 427(1):8\u201315. https:\/\/doi.org\/10.1016\/j.abb.2004.04.001","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"3594_CR57","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1515\/BC.2004.054","volume":"385","author":"A Wendt","year":"2004","unstructured":"Wendt A, Thompson VF, Goll DE (2004) Interaction of calpastatin with calpain: a review. Biol Chem 385(6):465\u2013472. https:\/\/doi.org\/10.1515\/BC.2004.054","journal-title":"Biol Chem"},{"issue":"3","key":"3594_CR58","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/brv.12686","volume":"96","author":"H Nian","year":"2021","unstructured":"Nian H, Ma B (2021) Calpain-calpastatin system and cancer progression. Biol Rev Camb Philos Soc 96(3):961\u2013975. https:\/\/doi.org\/10.1111\/brv.12686","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"5","key":"3594_CR59","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.neuron.2013.08.034","volume":"80","author":"J Yang","year":"2013","unstructured":"Yang J, Weimer RM, Kallop D, Olsen O, Wu Z, Renier N, Uryu K, Tessier-Lavigne M (2013) Regulation of axon degeneration after injury and in development by the endogenous calpain inhibitor calpastatin. Neuron 80(5):1175\u20131189. https:\/\/doi.org\/10.1016\/j.neuron.2013.08.034","journal-title":"Neuron"},{"key":"3594_CR60","doi-asserted-by":"publisher","first-page":"130345","DOI":"10.1016\/j.bbagen.2023.130345","volume":"5","author":"IM Kotova","year":"2023","unstructured":"Kotova IM, Pestereva NS, Traktirov DS, Absalyamova MT, Karpenko MN (2023) Functions and distribution of calpain-calpastatin system components in brain during mammal ontogeny. Biochim Biophys Acta Gen Subj 1867 5:130345. https:\/\/doi.org\/10.1016\/j.bbagen.2023.130345","journal-title":"Biochim Biophys Acta Gen Subj 1867"},{"issue":"3","key":"3594_CR61","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2174\/1568007033482887","volume":"2","author":"SK Ray","year":"2003","unstructured":"Ray SK, Banik NL (2003) Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord 2(3):173\u2013189. https:\/\/doi.org\/10.2174\/1568007033482887","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"3594_CR62","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/j.1749-6632.1999.tb08002.x","volume":"890","author":"K Blomgren","year":"1999","unstructured":"Blomgren K (1999) Calpastatin is upregulated and acts as a suicide substrate to calpains in neonatal rat hypoxia-ischemia. Ann N Y Acad Sci 890:270\u2013271. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb08002.x","journal-title":"Ann N Y Acad Sci"},{"issue":"15","key":"3594_CR63","doi-asserted-by":"publisher","first-page":"15229","DOI":"10.1074\/jbc.M500939200","volume":"280","author":"M Higuchi","year":"2005","unstructured":"Higuchi M, Tomioka M, Takano J, Shirotani K, Iwata N, Masumoto H, Maki M, Itohara S et al (2005) Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J Biol Chem 280(15):15229\u201315237. https:\/\/doi.org\/10.1074\/jbc.M500939200","journal-title":"J Biol Chem"},{"issue":"29","key":"3594_CR64","doi-asserted-by":"publisher","first-page":"17946","DOI":"10.1074\/jbc.M115.652396","volume":"290","author":"A Guo","year":"2015","unstructured":"Guo A, Hall D, Zhang C, Peng T, Miller JD, Kutschke W, Grueter CE, Johnson FL et al (2015) Molecular determinants of calpain-dependent cleavage of junctophilin-2 protein in cardiomyocytes. J Biol Chem 290(29):17946\u201317955. https:\/\/doi.org\/10.1074\/jbc.M115.652396","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"3594_CR65","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1042\/bj2960675","volume":"296","author":"Z Al","year":"1993","unstructured":"Al Z, Cohen CM (1993) Phorbol 12-myristate 13-acetate-stimulated phosphorylation of erythrocyte membrane skeletal proteins is blocked by calpain inhibitors: possible role of protein kinase M. Biochem J 296(Pt 3):675\u2013683. https:\/\/doi.org\/10.1042\/bj2960675","journal-title":"Biochem J"},{"key":"3594_CR66","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1476-9255-6-20","volume":"6","author":"T Liu","year":"2009","unstructured":"Liu T, Schneider RA, Shah V, Huang Y, Likhotvorik RI, Keshvara L, Hoyt DG (2009) Protein never in mitosis gene A interacting-1 regulates calpain activity and the degradation of cyclooxygenase-2 in endothelial cells. J Inflamm (Lond) 6:20. https:\/\/doi.org\/10.1186\/1476-9255-6-20","journal-title":"J Inflamm (Lond)"},{"issue":"1","key":"3594_CR67","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuint.2003.11.012","volume":"45","author":"S Cho","year":"2004","unstructured":"Cho S, Liu D, Fairman D, Jenkins Li P, McGonigle P, Wood A (2004) Spatiotemporal evidence of apoptosis-mediated ischemic injury in organotypic hippocampal slice cultures. Neurochem Int 45(1):117\u2013127. https:\/\/doi.org\/10.1016\/j.neuint.2003.11.012","journal-title":"Neurochem Int"},{"issue":"3","key":"3594_CR68","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.neulet.2004.06.043","volume":"367","author":"S Alavez","year":"2004","unstructured":"Alavez S, Moran J, Franco-Cea A, Ortega-G\u00f3mez A, Casaletti L, Cameron LC (2004) Myosin Va is proteolysed in rat cerebellar granule neurons after excitotoxic injury. Neurosci Lett 367(3):404\u2013409. https:\/\/doi.org\/10.1016\/j.neulet.2004.06.043","journal-title":"Neurosci Lett"},{"issue":"11","key":"3594_CR69","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1089\/089771501317095269","volume":"18","author":"NC Kupina","year":"2001","unstructured":"Kupina NC, Nath R, Bernath EE, Inoue J, Mitsuyoshi A, Yuen PW, Wang KK, Hall ED (2001) The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury. J Neurotrauma 18(11):1229\u20131240. https:\/\/doi.org\/10.1089\/089771501317095269","journal-title":"J Neurotrauma"},{"issue":"3","key":"3594_CR70","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/089771503321532842","volume":"20","author":"A Buki","year":"2003","unstructured":"Buki A, Farkas O, Doczi T, Povlishock JT (2003) Preinjury administration of the calpain inhibitor MDL-28170 attenuates traumatically induced axonal injury. J Neurotrauma 20(3):261\u2013268. https:\/\/doi.org\/10.1089\/089771503321532842","journal-title":"J Neurotrauma"},{"issue":"3","key":"3594_CR71","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1089\/neu.2005.22.398","volume":"22","author":"S Arataki","year":"2005","unstructured":"Arataki S, Tomizawa K, Moriwaki A, Nishida K, Matsushita M, Ozaki T, Kunisada T, Yoshida A et al (2005) Calpain inhibitors prevent neuronal cell death and ameliorate motor disturbances after compression-induced spinal cord injury in rats. J Neurotrauma 22(3):398\u2013406. https:\/\/doi.org\/10.1089\/neu.2005.22.398","journal-title":"J Neurotrauma"},{"issue":"9","key":"3594_CR72","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1248\/bpb.28.1651","volume":"28","author":"T Seki","year":"2005","unstructured":"Seki T, Wang MH, Miyata N, Laniado-Schwartzman M (2005) Cytochrome P450 4A isoform inhibitory profile of N-hydroxy-N\u2019-(4-butyl-2-methylphenyl)-formamidine (HET0016), a selective inhibitor of 20-HETE synthesis. Biol Pharm Bull 28(9):1651\u20131654. https:\/\/doi.org\/10.1248\/bpb.28.1651","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"3594_CR73","first-page":"415","volume":"43","author":"YW Shi","year":"2022","unstructured":"Shi YW, Wu X, Qu Y et al (2022) Het0016 alleviates brain injury by inhibiting excessive autophagy after traumatic brain injury. Journal of Air Force Medical University 43(4):415\u2013418","journal-title":"Journal of Air Force Medical University"},{"issue":"5","key":"3594_CR74","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nrm2393","volume":"9","author":"A Degterev","year":"2008","unstructured":"Degterev A, Yuan J (2008) Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 9(5):378\u2013390. https:\/\/doi.org\/10.1038\/nrm2393","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3594_CR75","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1471-4159.2012.07666.x","volume":"121","author":"ZJ Yang","year":"2012","unstructured":"Yang ZJ, Carter EL, Kibler KK, Kwansa H, Crafa DA, Martin LJ, Roman RJ, Harder DR et al (2012) Attenuation of neonatal ischemic brain damage using a 20-HETE synthesis inhibitor. J Neurochem 121(1):168\u2013179. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07666.x","journal-title":"J Neurochem"},{"issue":"3","key":"3594_CR76","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/jcp.29173","volume":"235","author":"Z Zeng","year":"2020","unstructured":"Zeng Z, Zhang Y, Jiang W, He L, Qu H (2020) Modulation of autophagy in traumatic brain injury. J Cell Physiol 235(3):1973\u20131985. https:\/\/doi.org\/10.1002\/jcp.29173","journal-title":"J Cell Physiol"},{"issue":"12","key":"3594_CR77","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/sj.jcbfm.9600309","volume":"26","author":"SM Poloyac","year":"2006","unstructured":"Poloyac SM, Zhang Y, Bies RR, Kochanek PM, Graham SH (2006) Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia. J Cereb Blood Flow Metab 26(12):1551\u20131561. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600309","journal-title":"J Cereb Blood Flow Metab"},{"key":"3594_CR78","first-page":"5","volume":"1","author":"XC Zhao","year":"2014","unstructured":"Zhao XC, An P, Wu XY (2014) Role of het0016 in mice with col1agenase-induced intracerebral hemorrhage. Prog Anat Sci 1:5","journal-title":"Prog Anat Sci"},{"issue":"3\u20134","key":"3594_CR79","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000500895","volume":"41","author":"S Shu","year":"2019","unstructured":"Shu S, Zhang Z, Spicer D, Kulikowicz E, Hu K, Babapoor-Farrokhran S, Kannan S, Koehler RC et al (2019) Administration of a 20-hydroxyeicosatetraenoic acid synthesis inhibitor improves outcome in a rat model of pediatric traumatic brain injury. Dev Neurosci 41(3\u20134):166\u2013176. https:\/\/doi.org\/10.1159\/000500895","journal-title":"Dev Neurosci"},{"issue":"4","key":"3594_CR80","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3892\/ijmm.2020.4479","volume":"45","author":"H Gao","year":"2020","unstructured":"Gao H, Cao Y, Xia H, Zhu X, Jin Y (2020) CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS-induced lipid peroxidation and inflammation. Int J Mol Med 45(4):1121\u20131129. https:\/\/doi.org\/10.3892\/ijmm.2020.4479","journal-title":"Int J Mol Med"},{"issue":"8","key":"3594_CR81","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1177\/0271678X18762645","volume":"39","author":"X Han","year":"2019","unstructured":"Han X, Zhao X, Lan X, Li Q, Gao Y, Liu X, Wan J, Yang Z et al (2019) 20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis. J Cereb Blood Flow Metab 39(8):1531\u20131543. https:\/\/doi.org\/10.1177\/0271678X18762645","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"3594_CR82","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/14737175.2017.1259567","volume":"17","author":"EP Yildiz","year":"2017","unstructured":"Yildiz EP, Ekici B, Tatli B (2017) Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment. Expert Rev Neurother 17(5):449\u2013459. https:\/\/doi.org\/10.1080\/14737175.2017.1259567","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"3594_CR83","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1891\/11-T-755","volume":"40","author":"K O'Mara","year":"2021","unstructured":"O\u2019Mara K, McPherson C (2021) Neuroprotective agents for neonates with hypoxic-ischemic encephalopathy. Neonatal Netw 40(6):406\u2013413. https:\/\/doi.org\/10.1891\/11-T-755","journal-title":"Neonatal Netw"},{"issue":"8","key":"3594_CR84","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1053\/j.semperi.2016.09.007","volume":"40","author":"G Natarajan","year":"2016","unstructured":"Natarajan G, Pappas A, Shankaran S (2016) Outcomes in childhood following therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy (HIE). Semin Perinatol 40(8):549\u2013555. https:\/\/doi.org\/10.1053\/j.semperi.2016.09.007","journal-title":"Semin Perinatol"},{"issue":"5","key":"3594_CR85","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1517\/13543776.2011.568480","volume":"21","author":"IO Donkor","year":"2011","unstructured":"Donkor IO (2011) Calpain inhibitors: a survey of compounds reported in the patent and scientific literature. Expert Opin Ther Pat 21(5):601\u2013636. https:\/\/doi.org\/10.1517\/13543776.2011.568480","journal-title":"Expert Opin Ther Pat"},{"issue":"9","key":"3594_CR86","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/13543776.2020.1797678","volume":"30","author":"IO Donkor","year":"2020","unstructured":"Donkor IO (2020) An update on the therapeutic potential of calpain inhibitors: a patent review. Expert Opin Ther Pat 30(9):659\u2013675. https:\/\/doi.org\/10.1080\/13543776.2020.1797678","journal-title":"Expert Opin Ther Pat"},{"issue":"6","key":"3594_CR87","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3892\/br.2016.785","volume":"5","author":"J Ji","year":"2016","unstructured":"Ji J, Su L, Liu Z (2016) Critical role of calpain in inflammation. Biomed Rep 5(6):647\u2013652. https:\/\/doi.org\/10.3892\/br.2016.785","journal-title":"Biomed Rep"},{"key":"3594_CR88","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejphar.2017.08.002","volume":"814","author":"V Kumar","year":"2017","unstructured":"Kumar V, Ahmad A (2017) Targeting calpains: a novel immunomodulatory approach for microbial infections. Eur J Pharmacol 814:28\u201344. https:\/\/doi.org\/10.1016\/j.ejphar.2017.08.002","journal-title":"Eur J Pharmacol"},{"key":"3594_CR89","doi-asserted-by":"publisher","first-page":"20","DOI":"10.31083\/j.fbl2701020","volume":"27","author":"A Gao","year":"2022","unstructured":"Gao A, Mcoy HM, Zaman V, Shields DC, Banik NL, Haque A (2022) Calpain activation and progression of inflammatory cycles in Parkinson\u2019s disease. Front Biosci (Landmark edition) 27:20. https:\/\/doi.org\/10.31083\/j.fbl2701020","journal-title":"Front Biosci (Landmark edition)"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03594-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03594-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03594-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T09:30:46Z","timestamp":1705397446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03594-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["3594"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03594-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"23 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and\/or Animals"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}